Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

Sudeck's atrophy in Lyme borreliosis.

Bruckbauer HR, Preac Mursic V, Herzer P, Hofmann H.

Infection. 1997 Nov-Dec;25(6):372-6.

PMID:
9427058
2.
3.
4.

Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development.

Wilske B, Busch U, Fingerle V, Jauris-Heipke S, Preac Mursic V, Rössler D, Will G.

Infection. 1996 Mar-Apr;24(2):208-12. Review.

PMID:
8740124
5.

Diversity of OspA and OspC among cerebrospinal fluid isolates of Borrelia burgdorferi sensu lato from patients with neuroborreliosis in Germany.

Wilske B, Busch U, Eiffert H, Fingerle V, Pfister HW, Rössler D, Preac-Mursic V.

Med Microbiol Immunol. 1996 Feb;184(4):195-201.

PMID:
8811652
6.

Borrelia burgdorferi sensu lato strains isolated from cutaneous Lyme borreliosis biopsies differentiated by pulsed-field gel electrophoresis.

Busch U, Hizo-Teufel C, Böhmer R, Fingerle V, Rössler D, Wilske B, Preac-Mursic V.

Scand J Infect Dis. 1996;28(6):583-9.

PMID:
9060061
7.

Kill kinetics of Borrelia burgdorferi and bacterial findings in relation to the treatment of Lyme borreliosis.

Preac Mursic V, Marget W, Busch U, Pleterski Rigler D, Hagl S.

Infection. 1996 Jan-Feb;24(1):9-16. Erratum in: Infection 1996 Mar-Apr;24(2):169.

PMID:
8852456
8.

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species.

Will G, Jauris-Heipke S, Schwab E, Busch U, Rössler D, Soutschek E, Wilske B, Preac-Mursic V.

Med Microbiol Immunol. 1995 Aug;184(2):73-80.

PMID:
7500914
9.

Expression of outer surface proteins A and C of Borrelia burgdorferi in Ixodes ricinus.

Fingerle V, Hauser U, Liegl G, Petko B, Preac-Mursic V, Wilske B.

J Clin Microbiol. 1995 Jul;33(7):1867-9.

10.

Molecular analysis of genes encoding outer surface protein C (OspC) of Borrelia burgdorferi sensu lato: relationship to ospA genotype and evidence of lateral gene exchange of ospC.

Jauris-Heipke S, Liegl G, Preac-Mursic V, Rössler D, Schwab E, Soutschek E, Will G, Wilske B.

J Clin Microbiol. 1995 Jul;33(7):1860-6.

11.

Molecular and immunological characterization of the p83/100 protein of various Borrelia burgdorferi sensu lato strains.

Rössler D, Eiffert H, Jauris-Heipke S, Lehnert G, Preac-Mursic V, Teepe J, Schlott T, Soutschek E, Wilske B.

Med Microbiol Immunol. 1995 May;184(1):23-32.

PMID:
8538575
12.

Molecular characterization of Borrelia burgdorferi sensu lato strains by pulsed-field gel electrophoresis.

Busch U, Teufel CH, Boehmer R, Wilske B, Preac-Mursic V.

Electrophoresis. 1995 May;16(5):744-7.

PMID:
7588556
13.

Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.

Wilske B, Jauris-Heipke S, Lobentanzer R, Pradel I, Preac-Mursic V, Rössler D, Soutschek E, Johnson RC.

J Clin Microbiol. 1995 Jan;33(1):103-9.

14.

Severe diarrhea associated with Arcobacter butzleri.

Lerner J, Brumberger V, Preac-Mursic V.

Eur J Clin Microbiol Infect Dis. 1994 Aug;13(8):660-2.

PMID:
7813498
15.

Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Wilske B, Fingerle V, Preac-Mursic V, Jauris-Heipke S, Hofmann A, Loy H, Pfister HW, Rössler D, Soutschek E.

Med Microbiol Immunol. 1994 Feb;183(1):43-59.

PMID:
8202030
16.

Molecular characterization of the p100 gene of Borrelia burgdorferi strain PKo.

Jauris-Heipke S, Fuchs R, Hofmann A, Lottspeich F, Preac-Mursic V, Soutschek E, Will G, Wilske B.

FEMS Microbiol Lett. 1993 Dec 1;114(2):235-41.

PMID:
8282192
17.

Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

Wilske B, Fingerle V, Herzer P, Hofmann A, Lehnert G, Peters H, Pfister HW, Preac-Mursic V, Soutschek E, Weber K.

Med Microbiol Immunol. 1993 Nov;182(5):255-70.

PMID:
8283961
18.

Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.

Dykhuizen DE, Polin DS, Dunn JJ, Wilske B, Preac-Mursic V, Dattwyler RJ, Luft BJ.

Proc Natl Acad Sci U S A. 1993 Nov 1;90(21):10163-7.

19.

Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.

Weber K, Wilske B, Preac-Mursic V, Thurmayr R.

Infection. 1993 Nov-Dec;21(6):367-72.

PMID:
8132365
20.

First isolation of Borrelia burgdorferi from an iris biopsy.

Preac-Mursic V, Pfister HW, Spiegel H, Burk R, Wilske B, Reinhardt S, Böhmer R.

J Clin Neuroophthalmol. 1993 Sep;13(3):155-61; discussion 162.

PMID:
8106639
21.

Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Wilske B, Preac-Mursic V, Jauris S, Hofmann A, Pradel I, Soutschek E, Schwab E, Will G, Wanner G.

Infect Immun. 1993 May;61(5):2182-91.

22.

Borrelia burgdorferi myositis: report of eight patients.

Reimers CD, de Koning J, Neubert U, Preac-Mursic V, Koster JG, Müller-Felber W, Pongratz DE, Duray PH.

J Neurol. 1993 May;240(5):278-83.

PMID:
8326331
23.

The antimicrobial actions of taurolin and other preparations on the pathogenic spectrum in dentoalveolar infections.

Zimmermann M, Preac-Mursic V.

Int J Clin Pharmacol Ther Toxicol. 1993 Mar;31(3):130-6.

PMID:
8468110
24.

Azithromycin versus doxycycline for treatment of erythema migrans: clinical and microbiological findings.

Strle F, Preac-Mursic V, Cimperman J, Ruzic E, Maraspin V, Jereb M.

Infection. 1993 Mar-Apr;21(2):83-8.

PMID:
8387966
25.

Genetic heterogenity of the genes coding for the outer surface protein C (OspC) and the flagellin of Borrelia burgdorferi.

Jauris-Heipke S, Fuchs R, Motz M, Preac-Mursic V, Schwab E, Soutschek E, Will G, Wilske B.

Med Microbiol Immunol. 1993 Mar;182(1):37-50.

PMID:
8098841
26.

Catatonic syndrome in acute severe encephalitis due to Borrelia burgdorferi infection.

Pfister HW, Preac-Mursic V, Wilske B, Rieder G, Förderreuther S, Schmidt S, Kapfhammer HP.

Neurology. 1993 Feb;43(2):433-5.

PMID:
8437717
27.

An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Wilske B, Preac-Mursic V, Göbel UB, Graf B, Jauris S, Soutschek E, Schwab E, Zumstein G.

J Clin Microbiol. 1993 Feb;31(2):340-50.

28.

Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection.

Preac-Mursic V, Wilske B, Patsouris E, Jauris S, Will G, Soutschek E, Rainhardt S, Lehnert G, Klockmann U, Mehraein P.

Infection. 1992 Nov-Dec;20(6):342-9.

PMID:
1293055
29.
30.

Cross-reactive proteins of Borrelia burgdorferi.

Bruckbauer HR, Preac-Mursic V, Fuchs R, Wilske B.

Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):224-32.

PMID:
1597198
31.

[Nodular panniculitis: a manifestation of Lyme borreliosis?].

Hassler D, Zorn J, Zöller L, Neuss M, Weyand C, Goronzy J, Born IA, Preac-Mursic V.

Hautarzt. 1992 Mar;43(3):134-8. German.

PMID:
1577601
32.

Molecular analysis and expression of a Borrelia burgdorferi gene encoding a 22 kDa protein (pC) in Escherichia coli.

Fuchs R, Jauris S, Lottspeich F, Preac-Mursic V, Wilske B, Soutschek E.

Mol Microbiol. 1992 Feb;6(4):503-9.

PMID:
1560779
33.

Genetic polymorphism of the gene encoding the outer surface protein A (OspA) of Borrelia burgdorferi.

Zumstein G, Fuchs R, Hofmann A, Preac-Mursic V, Soutschek E, Wilske B.

Med Microbiol Immunol. 1992;181(2):57-70.

PMID:
1406458
34.

Molecular analysis of the outer surface protein A (OspA) of Borrelia burgdorferi for conserved and variable antibody binding domains.

Wilske B, Luft B, Schubach WH, Zumstein G, Jauris S, Preac-Mursic V, Kramer MD.

Med Microbiol Immunol. 1992;181(4):191-207.

PMID:
1279368
35.

Culture of Borrelia burgdorferi on six solid media.

Preac-Mursic V, Wilske B, Reinhardt S.

Eur J Clin Microbiol Infect Dis. 1991 Dec;10(12):1076-9.

PMID:
1802702
36.

Isolation of Borrelia burgdorferi from a skin lesion in a patient with granuloma annulare.

Strle F, Preac-Mursic V, Ruzic E, Wilske B, Cimperman J.

Infection. 1991 Sep-Oct;19(5):351-2. No abstract available.

PMID:
1800376
37.

[Diagnosis of Lyme neuroborreliosis. Detection of intrathecal antibody formation].

Wilske B, Bader L, Pfister HW, Preac-Mursic V.

Fortschr Med. 1991 Jul 30;109(22):441-6. Review. German.

PMID:
1937323
38.

Pulsed high-dose cefotaxime therapy in refractory Lyme borreliosis.

Hassler D, Riedel K, Zorn J, Preac-Mursic V.

Lancet. 1991 Jul 20;338(8760):193. No abstract available.

PMID:
1677097
39.

Immunodominant proteins of Borrelia burgdorferi, the etiological agent of lyme borreliosis.

Wilske B, Preac-Mursic V, Fuchs R, Soutschek E.

World J Microbiol Biotechnol. 1991 Mar;7(2):130-6. doi: 10.1007/BF00328982.

PMID:
24424924
40.

Randomized comparison of ceftriaxone and cefotaxime in Lyme neuroborreliosis.

Pfister HW, Preac-Mursic V, Wilske B, Schielke E, Sörgel F, Einhäupl KM.

J Infect Dis. 1991 Feb;163(2):311-8.

PMID:
1988514
41.

[The periodontal findings and microflora in insulin-dependent (type 1) diabetics].

Willershausen B, Barth S, Preac-Mursic V, Haslbeck M.

Schweiz Monatsschr Zahnmed. 1991;101(11):1399-404. German.

PMID:
1962163
42.

Antibiotic susceptibility of Borrelia burgdorferi in vitro and in animal models.

Wretlind B, Johnson RC, Hansen K, Preac-Mursic V.

Scand J Infect Dis Suppl. 1991;77:143-4.

PMID:
1947803
43.

Diagnostic tests in Lyme borreliosis.

Stiernstedt G, Dattwyler R, Duray PH, Hansen K, Jirous J, Johnson RC, Karlsson M, Preac-Mursic V, Schwan TG.

Scand J Infect Dis Suppl. 1991;77:136-42. No abstract available.

PMID:
1947802
44.

Taxonomy of Borrelia spp.

Wilske B, Anderson JF, Baranton G, Barbour AG, Hovind-Hougen K, Johnson RC, Preac-Mursic V.

Scand J Infect Dis Suppl. 1991;77:108-29.

PMID:
1947800
45.

Purification of the Borrelia burgdorferi flagellum by use of a monoclonal antibody.

Fuchs R, Wilske B, Preac-Mursic V, Schierz G.

Mol Cell Probes. 1990 Dec;4(6):451-62.

PMID:
2087234
46.
47.

Persistent atrioventricular block in Lyme borreliosis.

Mayer W, Kleber FX, Wilske B, Preac-Mursic V, Maciejewski W, Sigl H, Holzer E, Doering W.

Klin Wochenschr. 1990 Apr 17;68(8):431-5.

PMID:
2348647
48.

A randomized trial of ceftriaxone versus oral penicillin for the treatment of early European Lyme borreliosis.

Weber K, Preac-Mursic V, Wilske B, Thurmayr R, Neubert U, Scherwitz C.

Infection. 1990 Mar-Apr;18(2):91-6.

PMID:
2185158
49.

Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study.

Pfister HW, Preac-Mursic V, Wilske B, Einhäupl KM.

Arch Neurol. 1989 Nov;46(11):1190-4.

PMID:
2684107
50.

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis.

Preac-Mursic V, Weber K, Pfister HW, Wilske B, Gross B, Baumann A, Prokop J.

Infection. 1989 Nov-Dec;17(6):355-9.

PMID:
2613324

Supplemental Content

Loading ...
Support Center